Sex differences in kidney gene expression during the life cycle of F344 rats

Biology of Sex Differences

Volumn 4, Issue 1, 2013, Pages

  Kwekel, Joshua C ^a   Desai, Varsha G ^a   Moland, Carrie L ^a   Vijay, Vikrant ^a   Fuscoe, James C ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Age; Biomarker; Gene expression; Kidney; Sex

Indexed keywords

EID: 84886090800     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-4-14     Document Type: Article

References (31)

1. Trevisan A, Chiara F, Mongillo M, Quintieri L, Cristofori P: Sex-related differences in renal toxicodynamics in rodents. Expert Opin Drug Metab Toxicol 2012, 8(9):1173-1188.
2. Sabolic I, Asif AR, Budach WE, Wanke C, Bahn A, Burckhardt G: Gender differences in kidney function. Pflugers Arch 2007, 455(3):397-429. (Pubitemid 47624202)
3. McGuire BB, Watson RW, Perez-Barriocanal F, Fitzpatrick JM, Docherty NG: Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney. Kidney Blood Press Res 2007, 30(2):67-80. (Pubitemid 46674911)
4. Kang AK, Miller JA: Impact of gender on renal disease: the role of the renin angiotensin system. Clin Invest Med 2003, 26(1):38-44. (Pubitemid 36629705)
5. Kang DH, Yu ES, Yoon KI, Johnson R: The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004, 164(2):679-688. (Pubitemid 38364681)
6. Silbiger S, Neugarten J: Gender and human chronic renal disease. Gend Med 2008, 5:S3-S10. (Pubitemid 351455227)
7. Silbiger SR, Neugarten J: The role of gender in the progression of renal disease. Adv Ren Replace Ther 2003, 10(1):3-14. (Pubitemid 36278325)
8. Seliger SL, Davis C, Stehman-Breen C: Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 2001, 10(2):219-225. (Pubitemid 32221764)
9. Yu MK, Lyles CR, Bent-Shaw LA, Young BA: Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study. Am J Nephrol 2012, 36(3):245-251.
10. Sweileh WM: Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study. Curr Clin Pharmacol 2009, 4(3):229-232.
11. Omara EA, Aly HF, Nada SA: Chitosan induced hepato-nephrotoxicity in mice with special reference to gender effect in glycolytic enzymes activities. Regul Toxicol Pharmacol 2012, 62(1):29-40.
12. Al-Rejaie SS, Abuohashish HM, Alkhamees OA, Aleisa AM, Alroujayee AS: Gender difference following high cholesterol diet induced renal injury and the protective role of rutin and ascorbic acid combination in Wistar albino rats. Lipids Health Dis 2012, 11:41.
13. Hazelhoff MH, Bulacio RP, Torres AM: Gender related differences in kidney injury induced by mercury. Int J Mol Sci 2012, 13(8):10523-10536.
14. Bloor ID, Sebert SP, Mahajan RP, Symonds ME: The influence of sex on early stage markers of kidney dysfunction in response to juvenile obesity. Hypertension 2012, 60(4):991-997.
15. Kola I, Landis J: Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004, 3(8):711-715. (Pubitemid 39173511)
16. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002, 62(1):237-244. (Pubitemid 34754067)
17. Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, Staedtler F, Mahl A, Grenet O, Roth DR, Wahl D, Legay F, Holder D, Erdos Z, Vlasakova K, Jin H, Yu Y, Muniappa N, Forest T, Clouse HK, Reynolds S, Bailey WJ, Thudium DT, Topper MJ, Skopek TR, Sina JF, Glaab WE, Vonderscher J, Maurer G, Chibout SD, et al: A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 2010, 28(5):486-494.
18. Mendrick DL: Transcriptional profiling to identify biomarkers of disease and drug response. Pharmacogenomics 2011, 12(2):235-249.
19. Kwekel JC, Desai VG, Moland CL, Branham WS, Fuscoe JC: Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics 2010, 11:675.
20. Fang H, Harris SC, Su Z, Chen M, Qian F, Shi L, Perkins R, Tong W: Array Track: an FDA and public genomic tool. Methods Mol Biol 2009, 563:379-398.
21. Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, End P, Staedtler F, Legay F, Carl K, Laurie D, Chibout SD, Vonderscher J, Maurer G: Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 2010, 28(5):463-469.
22. Quinn R: Comparing rat's to human's age: how old is my rat in people years? Nutrition 2005, 21(6):775-777. (Pubitemid 40733575)
23. Madeddu P, Vio CP, Straino S, Salis MB, Milia AF, Emanueli C: Renal phenotype of low kallikrein rats. Kidney Int 2001, 59(6):2233-2242. (Pubitemid 32467616)
24. Miyazawa M, Shindo M, Shimada T: Sex differences in the metabolism of (+)-and (-)-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome p450 enzymes in rat liver microsomes. Chem Res Toxicol 2002, 15(1):15-20. (Pubitemid 34106085)
25. National Toxicology Program: NTP toxicology and carcinogenesis studies of d-limonene (CAS No. 5989-27-5) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 1990, 347:1-165.
26. Pfeiffer E, Metzler M: Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision-cut rat liver slices. Arch Toxicol 2004, 78(7):369-377. (Pubitemid 39062229)
27. Klaassen CD, Aleksunes LM: Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010, 62(1):1-96.
28. Kasenda B, Rehberg M, Thurmann P, Franzem M, Veelken H, Fritsch K, Schorb E, Finke J, Lebiedz D, Illerhaus G: The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients. Ann Hematol 2012, 91(8):1257-1264.
29. Iwano S, Higashi E, Miyoshi T, Ando A, Miyamoto Y: Focused DNA microarray analysis for sex-dependent gene expression of drug metabolizing enzymes, transporters and nuclear receptors in rat livers and kidneys. J Toxicol Sci 2012, 37(4):863-869.
30. Waxman DJ, Holloway MG: Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009, 76(2):215-228.
31. Espandiari P, Rosenzweig B, Zhang J, Zhou Y, Schnackenberg L, Vaidya VS, Goering PL, Brown RP, Bonventre JV, Mahjoob K, Holland RD, Beger RD, Thompson K, Hanig J, Sadrieh N: Age-related differences in susceptibility to cisplatin-induced renal toxicity. J Appl Toxicol 2010, 30(2):172-182.